3,5-Pyridinedicarboxylic acid, 1,2-dihydro- | 137840-06-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3,5-Pyridinedicarboxylic acid, 1,2-dihydro-
• 英文别名: 1,2-dihydropyridine-3,5-dicarboxylic acid
• CAS: 137840-06-3
• 化学式: C₇H₇NO₄
• 分子量: 169.13
• InChiKey: YIEDXDAMWYTGHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  86.6
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• METHODS AND SYSTEMS FOR DESIGNING AND/OR CHARACTERIZING SOLUBLE LIPIDATED LIGAND AGENTS
  申请人：TUFTS MEDICAL CENTER

  公开号：US20160052982A1

  公开（公告）日：2016-02-25

  The present application provides methods for preparing soluble lipidated ligand agents comprising a ligand entity and a lipid entity, and in some embodiments, provides relevant parameters of each of these components, thereby enabling appropriate selection of components to assemble active agents for any given target of interest.

  本申请提供了制备可溶性脂质化配体药剂的方法，包括配体实体和脂质实体，并在某些实施例中提供了这些组分的相关参数，从而使得能够适当选择组分来组装出针对任何感兴趣的靶点的活性药剂。
• [EN] MINERALOCORTICOID RECEPTOR MODULATORS<br/>[FR] MODULATEURS DES RÉCEPTEURS MINÉRALOCORTICOÏDES
  申请人：MERCK & CO INC

  公开号：WO2009078934A1

  公开（公告）日：2009-06-25

  The present invention relates to dihydropyridine mineralcorticoid receptor modulating compounds having the structure: and their use in treating cardiovascular events.

  本发明涉及具有以下结构的二氢吡啶矿物皮质激素受体调节化合物：以及它们在治疗心血管事件中的用途。
• 1,4-Dihydropyridine derivatives
  申请人：Korea Research Institute of Chemical Technology

  公开号：EP0324626A1

  公开（公告）日：1989-07-19

  1,4-dihydropyridine derivatives represented by the formula: wherein R¹ and R², different from the other, is selected from the group consisting of lower alkyl, lower alkenyl, lower alkoxyalkyl or aminoaryl(lower)alkyl having carbon atoms of 1 to 6, which may be substituted or unsubstituted by a lower alkyl having carbon atoms of 1 to 4, wherein at least one of R¹ and R² is a lower alkenyl having carbon atoms of 3 to 6 whose 1- or 2- position is substituted by a lower alkyl having carbon atoms of 1 to 4; and R³ is a nitro group in ortho-, meta- or para-position of the phenyl. The compounds are useful as vasodilators and in the treatment of hypertension.

  1,4-二氢吡啶衍生物的化学式表示为：其中R¹和R²，不同于另一个，选自由1至6个碳原子的较低烷基、较低烯基、较低烷氧基烷基或氨基芳基(较低)烷基组成的基团，该基团可能被1至4个碳原子的较低烷基取代或未取代，其中R¹和R²中至少一个是碳原子为3至6的较低烯基，其1-或2-位置被1至4个碳原子的较低烷基取代；以及R³是苯环的邻位、间位或对位的硝基基团。这些化合物可用作扩血管剂，并用于治疗高血压。
• Processes of manufacturing substituted-1,4-dihydropyridines, improved aqueous solutions thereof, and processes of manufacturing the solutions
  申请人：Jobdevairakkam Christopher N.

  公开号：US20080125595A1

  公开（公告）日：2008-05-29

  A process of preparing a stable parenteral solution of a 1,4-dihydropyridine salt, such as nicardipine hydrochloride, in an acidic aqueous medium. The presence of L-arginine in the solution enhances the solubility of the salt, which is poorly soluble in water. An aqueous, injectable isotonic solution at pH about 3.5-3.6 consists essentially of nicardipine hydrochloride, L-arginine, and a sugar alcohol. An improved single pot manufacturing process for obtaining unsymmetrical 1,4-dihydropyridines by using more than one mole equivalent of aldehyde with respect to the other reactants (amino crotonate and acetoacetate ester). The reaction can be conducted in a solvent present at 20 times the amount of any one component. A process for changing one polymorph of nicardipine hydrochloride (Form A) into another (Form B), and a separate process for the reverse (Form B into Form A).

  一种制备1,4-二氢吡啶盐（如盐酸尼卡地平）的稳定无菌溶液的工艺，该工艺在酸性水介质中进行。溶液中存在L-精氨酸，可增强盐的溶解度，而盐在水中溶解度较差。该无菌溶液为水溶性、注射用的等渗溶液，pH值约为3.5-3.6，主要由盐酸尼卡地平、L-精氨酸和糖醇组成。 一种改进的单锅制造工艺，用于通过使用超过其他反应物（氨基丙烯酸酯和乙酰乙酸酯）的摩尔当量的醛类来获得非对称的1,4-二氢吡啶。该反应可以在溶剂中进行，溶剂的量为任何一个组分的20倍。 一种将尼卡地平盐酸的一种多晶形式（A型）转变为另一种多晶形式（B型）的工艺，以及将B型转变为A型的单独工艺。
• 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same
  申请人：FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC.

  公开号：EP0161877A2

  公开（公告）日：1985-11-21

  1,4-dihydropyridine derivatives having hypotensive action whose time to take effect is long so that blood pressure drops slowly, and whose toxicity is low possess the following general formula wherein specifically R3 is a combined group formed from an unsaturated straight chain hydrocarbon or derivative thereof with (1) an unsaturated hydrocarbyl group or (2) an aryl or hydroaromatic group. A carbon atom of an unsaturated group of the unsaturated hydrocarbon(s) or a ring carbon atom of the aryl or hydroaromatic group is connected to a carbon atom of an unsaturated group of the unsaturated straight chain hydrocarbon or derivative thereof.

  具有降压作用的 1,4-二氢吡啶衍生物，起效时间长，血压下降缓慢，毒性低，通式如下 其中，R3 是由不饱和直链烃或其衍生物与(1)不饱和烃基或(2)芳基或芳香族基团形成的组合基团。不饱和烃的不饱和基团的碳原子或芳基或烃基的环碳原子与不饱和直链烃或其衍生物的不饱和基团的碳原子相连。